Literature DB >> 16996269

POZ for effect--POZ-ZF transcription factors in cancer and development.

Kevin F Kelly1, Juliet M Daniel.   

Abstract

The BTB/POZ-ZF [Broad complex, Tramtrack, Bric à brac (BTB) or poxvirus and zinc finger (POZ)-zinc finger] protein family comprises a diverse group of transcription factors. POZ-ZF proteins have been implicated in many biological processes, including B cell fate determination, DNA damage responses, cell cycle progression and a multitude of developmental events, including gastrulation, limb formation and hematopoietic stem cell fate determination. Consequently, dysfunction of vertebrate POZ-ZF proteins, such as promyelocytic leukemia zinc finger (PLZF), B cell lymphoma 6 (Bcl-6), hypermethylated in cancer 1 (HIC-1), Kaiso, ZBTB7 and Fanconi anemia zinc finger (FAZF), has been linked directly or indirectly to tumorigenesis and developmental disorders. Here, we discuss recent advances in the POZ-ZF field and the implications for the design of future studies to elucidate the biological roles of these unique transcription factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996269     DOI: 10.1016/j.tcb.2006.09.003

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  114 in total

1.  Clld7, a candidate tumor suppressor on chromosome 13q14, regulates pathways of DNA damage/repair and apoptosis.

Authors:  Xiaobo Zhou; Karl Münger
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  The novel BTB/POZ and zinc finger factor Zbtb45 is essential for proper glial differentiation of neural and oligodendrocyte progenitor cells.

Authors:  Erik Södersten; Tobias Lilja; Ola Hermanson
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

3.  Kaiso uses all three zinc fingers and adjacent sequence motifs for high affinity binding to sequence-specific and methyl-CpG DNA targets.

Authors:  Bethany A Buck-Koehntop; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  FEBS Lett       Date:  2012-01-30       Impact factor: 4.124

Review 4.  A system biology approach to identify regulatory pathways underlying the neuroendocrine control of female puberty in rats and nonhuman primates.

Authors:  Alejandro Lomniczi; Hollis Wright; Juan Manuel Castellano; Kemal Sonmez; Sergio R Ojeda
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

Review 5.  Alternative memory in the CD8 T cell lineage.

Authors:  You Jeong Lee; Stephen C Jameson; Kristin A Hogquist
Journal:  Trends Immunol       Date:  2011-02-01       Impact factor: 16.687

6.  Structure of the wild-type human BCL6 POZ domain.

Authors:  Mark A Stead; Gareth O Rosbrook; Jonathan M Hadden; Chi H Trinh; Stephen B Carr; Stephanie C Wright
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-11-28

Review 7.  Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.

Authors:  Arnab Ghosh; Amanda M Holland; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.

Authors:  Min-Kyeong Kim; Bu-Nam Jeon; Dong-In Koh; Kyung-Sup Kim; So-Yoon Park; Chae-Ok Yun; Man-Wook Hur
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

9.  The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions.

Authors:  Damian Kovalovsky; Olisambu U Uche; Sonia Eladad; Robin M Hobbs; Woelsung Yi; Eric Alonzo; Kevin Chua; Maggie Eidson; Hye-Jung Kim; Jin S Im; Pier Paolo Pandolfi; Derek B Sant'Angelo
Journal:  Nat Immunol       Date:  2008-07-27       Impact factor: 25.606

10.  A feedback loop mediated by degradation of an inhibitor is required to initiate neuronal differentiation.

Authors:  Dorothy F Sobieszczuk; Alexei Poliakov; Qiling Xu; David G Wilkinson
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.